5,392 results
·
48ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 2
×
Adaptive Biotechnologies clonoSEQ Assay
FDA 510(k)
FDA Class 2
·Pathology
VENTANA CD30 (Ber-H2) RxDx Assay
FDA 510(k)
FDA Class 2
·Immunology
xTAG Cystic Fibrosis 60 Kit v2, xTAG Data Analysis Software (TDAS) CFTR
FDA 510(k)
FDA Class 2
·Immunology
Parsortix PC1 Device
FDA 510(k)
FDA Class 2
·Immunology
GenetiSure Dx Postnatal Assay
FDA 510(k)
FDA Class 2
·Immunology
xTAG Cystic Fibrosis 39 Kit v2
FDA 510(k)
FDA Class 2
·Immunology
Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers
FDA Pre-Market Approval
FDA Class 2
·ELECSYS FREE PSA IMMUNOASSAY/CALSET/CALCHECK
Lift, Patient, Ac-Powered
FDA classification
FDA Class 2
·Lift, Patient, Ac-Powered
Free Radical, Benzoylecgnonine
FDA classification
FDA Class 2
·Free Radical, Benzoylecgnonine
Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers
FDA Pre-Market Approval
FDA Class 2
·ELECSYS FREE PSA IMMUNOASSAY/CALSET/CALCHEK
Assisted Reproduction Laminar Flow Workstation
FDA classification
FDA Class 2
·Assisted Reproduction Laminar Flow Workstation
Analyzer, Body Composition, Exempt
FDA classification
FDA Class 2
·Analyzer, Body Composition, Exempt
Accessory, Assisted Reproduction, Exempt
FDA classification
FDA Class 2
·Accessory, Assisted Reproduction, Exempt
Dna And Rna Oncology Controls
FDA classification
FDA Class 2
·Dna And Rna Oncology Controls
Hematopoietic Cell Enrichment Kit
FDA classification
FDA Class 2
·Hematopoietic Cell Enrichment Kit
Kappa And Lambda Immunoglobulin Light Chain In Situ Hybridization Mrna Probe Detection Kit
FDA classification
FDA Class 2
·Kappa And Lambda Immunoglobulin Light Chain In Situ Hybridization Mrna Probe Detection Kit
Spinal Muscular Atrophy Newborn Screening Test System
FDA classification
FDA Class 2
·Spinal Muscular Atrophy Newborn Screening Test System
Quality Control Material, Genetics, Rna
FDA classification
FDA Class 2
·Quality Control Material, Genetics, Rna
Fish Based Detection Of Chromosomal Abnormalities From Patients With Hematologic Malignancies
FDA classification
FDA Class 2
·Fish Based Detection Of Chromosomal Abnormalities From Patients With Hematologic Malignancies
Cancer Predisposition Risk Assessment System
FDA classification
FDA Class 2
·Cancer Predisposition Risk Assessment System